Combination Drug Delivery Strategy for the Treatment of Multidrug Resistant Ovarian Cancer
Author:
Affiliation:
1. Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College Street, Toronto, Ontario, Canada, M5S 3M2
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Pharmaceutical Science,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/mp100323z
Reference46 articles.
1. Ovarian cancer
2. The epigenetics of ovarian cancer drug resistance and resensitization
3. Ovarian cancer: strategies for overcoming resistance to chemotherapy
4. An overview of cancer multidrug resistance: a still unsolved problem
5. Targeting multidrug resistance in cancer
Cited by 48 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Revamping precision treatment with nanoparticles envisaging effective drug delivery systems for ovarian cancer;Process Biochemistry;2024-03
2. Role of SLC7A11/xCT in Ovarian Cancer;International Journal of Molecular Sciences;2024-01-02
3. Silencing HDAC1 Expression Regulates Extracellular Regulated Protein Kinases/Mitogen-Activated Protein Kinase Signaling Activation and Enhances Chemosensitivity of Ovarian Carcinoma;Journal of Biomedical Nanotechnology;2024-01-01
4. Dual-functional extracellular vesicles enable synergistic treatment via m6A reader YTHDF1-targeting epigenetic regulation and chemotherapy;Nano Research;2023-10-13
5. Pharmacological Activity of Cepharanthine;Molecules;2023-06-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3